Scholarlink

<p>The coronavirus disease 2019 pandemic substantially impacted the delivery of cancer services and programs. Here we reviewed and synthesized the global scale and impact of pandemic-related delays and disruptions on cancer services, including diagnosis, diagnostic procedures, screening, treatment and supportive and palliative care. Based on data from 245 articles in 46 countries, we observed declines in the number of cancer screening participation (39.0%), diagnoses (23.0%), diagnostic procedures (24.0%) and treatment (28.0%), ranging from a 15.0% decline for radiotherapy to a 35.0% decline for systemic treatment during the pandemic compared to during the prepandemic period. Medium-human development index (HDI) category countries experienced greater reductions than high- and very-high-HDI countries. Missing data from low-HDI countries emphasize the need for increased investments in cancer surveillance and research in these settings. PROSPERO registration: <a href="https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=301816">CRD42022301816</a></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis

  • 期刊论文

  • 发表日期：

    2025年1月2日

查看全文
  • Richa Shah,
  • Nader Mounir Hanna,
  • Ching Ee Loo,
  • Michael David,
  • Allini Mafra,
  • Hanna Fink,
  • Ethna McFerran,
  • Montse Garcia,
  • Robabeh Ghodssighassemabadi,
  • Suryakanta Acharya,
  • Jean Niyibaga,
  • Oliver Langselius,
  • Clara Frick,
  • Nwamaka Lasebikan,
  • Jerome Vignat,
  • Julia Steinberg,
  • Suzanne Hughes,
  • Colleen Elizabeth Kircher,
  • Catherine Lindsay Goldie,
  • Sam Egger,
  • Richard Sullivan,
  • Ophira Ginsburg,
  • Freddie Bray,
  • Michael Caruana,
  • Harriet Hui,
  • André Michel Ilbawi,
  • Karen Canfell,
  • Isabelle Soerjomataram

摘要

The coronavirus disease 2019 pandemic substantially impacted the delivery of cancer services and programs. Here we reviewed and synthesized the global scale and impact of pandemic-related delays and disruptions on cancer services, including diagnosis, diagnostic procedures, screening, treatment and supportive and palliative care. Based on data from 245 articles in 46 countries, we observed declines in the number of cancer screening participation (39.0%), diagnoses (23.0%), diagnostic procedures (24.0%) and treatment (28.0%), ranging from a 15.0% decline for radiotherapy to a 35.0% decline for systemic treatment during the pandemic compared to during the prepandemic period. Medium-human development index (HDI) category countries experienced greater reductions than high- and very-high-HDI countries. Missing data from low-HDI countries emphasize the need for increased investments in cancer surveillance and research in these settings. PROSPERO registration: CRD42022301816